IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,003,268 | +7.0% | 463,035 | -3.2% | 0.39% | +14.7% |
| Q2 2023 | $19,620,710 | +11.9% | 478,204 | -2.5% | 0.34% | -5.3% |
| Q1 2023 | $17,536,010 | -6.2% | 490,655 | -0.8% | 0.36% | -11.8% |
| Q4 2022 | $18,686,707 | -15.7% | 494,750 | -1.2% | 0.41% | -20.0% |
| Q3 2022 | $22,154,000 | +16.0% | 500,890 | -2.9% | 0.51% | +22.4% |
| Q2 2022 | $19,097,000 | -1.2% | 515,859 | -1.2% | 0.42% | +21.6% |
| Q1 2022 | $19,334,000 | +17.4% | 521,968 | -3.5% | 0.34% | +20.4% |
| Q4 2021 | $16,464,000 | -9.6% | 541,044 | -0.4% | 0.28% | -15.5% |
| Q3 2021 | $18,220,000 | -15.6% | 543,226 | +0.3% | 0.34% | -13.8% |
| Q2 2021 | $21,594,000 | -6.4% | 541,342 | +5.5% | 0.39% | -11.4% |
| Q1 2021 | $23,070,000 | -26.3% | 513,124 | -7.4% | 0.44% | -30.8% |
| Q4 2020 | $31,318,000 | +13.2% | 553,914 | -5.0% | 0.64% | -3.2% |
| Q3 2020 | $27,657,000 | -22.0% | 582,869 | -3.1% | 0.66% | -24.9% |
| Q2 2020 | $35,476,000 | +20.7% | 601,697 | -3.2% | 0.88% | -2.0% |
| Q1 2020 | $29,404,000 | -30.7% | 621,909 | -11.5% | 0.89% | -3.9% |
| Q4 2019 | $42,442,000 | -7.8% | 702,559 | -8.5% | 0.93% | -14.3% |
| Q3 2019 | $46,008,000 | -10.5% | 767,960 | -4.0% | 1.08% | -10.0% |
| Q2 2019 | $51,433,000 | -27.8% | 800,268 | -8.9% | 1.20% | -25.2% |
| Q1 2019 | $71,270,000 | +45.0% | 878,031 | -3.4% | 1.61% | +26.9% |
| Q4 2018 | $49,138,000 | -1.8% | 908,946 | -6.3% | 1.27% | +22.3% |
| Q3 2018 | $50,036,000 | +9.9% | 970,065 | -11.3% | 1.04% | +10.8% |
| Q2 2018 | $45,549,000 | -16.9% | 1,093,098 | -12.1% | 0.94% | -12.8% |
| Q1 2018 | $54,834,000 | -15.4% | 1,243,975 | -3.5% | 1.08% | -13.7% |
| Q4 2017 | $64,848,000 | -8.5% | 1,289,221 | -7.8% | 1.25% | -4.7% |
| Q3 2017 | $70,902,000 | -3.6% | 1,398,465 | -3.3% | 1.31% | -7.6% |
| Q2 2017 | $73,587,000 | +20.9% | 1,446,564 | -4.5% | 1.41% | +21.6% |
| Q1 2017 | $60,891,000 | -19.0% | 1,514,710 | -3.6% | 1.16% | -23.3% |
| Q4 2016 | $75,191,000 | +23.9% | 1,572,045 | -5.1% | 1.52% | +24.7% |
| Q3 2016 | $60,676,000 | +55.0% | 1,656,017 | -1.5% | 1.22% | +44.4% |
| Q2 2016 | $39,137,000 | -43.1% | 1,680,412 | -1.0% | 0.84% | -42.7% |
| Q1 2016 | $68,744,000 | -34.3% | 1,697,378 | +0.4% | 1.47% | -33.1% |
| Q4 2015 | $104,678,000 | – | 1,690,263 | – | 2.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |